Drug & supplement interaction

Niacin + Tralokinumab-ldrm

Tralokinumab-ldrm brand name: Adbry.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Niacin and Tralokinumab-ldrm in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Niacin and Tralokinumab-ldrm

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Tralokinumab-ldrm and Niacin in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Niacin safety at a glance

Niacin overall Use caution Normal dietary amounts are safe, but high supplemental doses can cause flushing, liver problems, and other effects.
Pregnancy Likely Safe When used orally in amounts that do not exceed the tolerable upper intake level (UL). The UL of niacin during pregnancy and lactation is 30 mg daily for 14-18 y... Read the full pregnancy detail
Breastfeeding Likely Safe When used orally in amounts that do not exceed the tolerable upper intake level (UL). The UL of niacin during pregnancy and lactation is 30 mg daily for 14-18 y... Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Tralokinumab-ldrm and Niacin? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Tralokinumab-ldrm

Interactions in our licensed database are recorded against drug classes, not just single drug names. Tralokinumab-ldrm is filed under a single classification — immunosuppressants. Niacin has documented interactions with 15 drug classes — the most serious being alcohol (ethanol) (moderate), allopurinol (zyloprim) (moderate) and anticoagulant/antiplatelet drugs (moderate) — and none of Tralokinumab-ldrm’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Niacin Does Interact With Other Medications

Niacin has 727 moderate known drug interactions in our database — Tralokinumab-ldrm isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Niacin

Covers the 2,830 medications we’ve checked against Niacin. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Niacin and Tralokinumab-ldrm May Share a Side Effect

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

  • Swelling Additional detail

    Niacin

    “Orally, chronic use of large amounts of niacin has been associated with dry eyes, toxic amblyopia, blurred vision, eyelid swelling, eyelid discoloration, loss of eyebrows and eyelashes, proptosis, keratitis, macular edema, and cystic maculopathy, which appear to be dose-dependent and reversible.”

    Niacin · Natural Medicines adverse-effect record, reported in dry eye.

    3 sources cited
    1. 4863. American Society of Health-System Pharmacists. ASHP Therapeutic Position Statement on the safe use of niacin in the management of dyslipidemias. Am J Health Syst Pharm 1997;54:2815-9. DOI
    2. 6243. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (2000). Washington, DC: National Academy Press, 2000. Available at: http://b
    3. 26112. Fraunfelder FW, Fraunfelder FT, Illingworth DR. Adverse ocular effects associated with niacin therapy. Br J Ophthalmol 1995;79:54-56. PubMed

    Tralokinumab-ldrm

    Listed in the ADVERSE REACTIONS section of the FDA label for Tralokinumab-ldrm. Read the label on DailyMed ›

Reported for Niacin but not commonly for Tralokinumab-ldrm: stomach upset, liver problems, a low platelet count and a stroke or mini-stroke.

Effects for Tralokinumab-ldrm come from the ADVERSE REACTIONS section of its FDA label; effects for Niacin come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 5,530 voluntary FDA FAERS reports for Tralokinumab-ldrm that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Special populations

Niacin in Pregnancy & Breastfeeding

Pregnancy And Lactation Likely Safe

When used orally in amounts that do not exceed the tolerable upper intake level (UL). The UL of niacin during pregnancy and lactation is 30 mg daily for 14-18 years of age and 35 mg daily for 19 years and older. There is insufficient reliable information available about the safety of larger oral doses of niacin during pregnancy or lactation; avoid using.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Everything else you take

See Every Supplement That Interacts With Tralokinumab-ldrm

This page covers Niacin only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Tralokinumab-ldrm page lists 53 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Active Hexose Correlated Compound (ahcc) (moderate), Alfalfa (moderate), American Ginseng (moderate), Andrographis (moderate) and Ashwagandha (moderate).

By severity: 52 moderate · 1 minor.

Open the Tralokinumab-ldrm interaction page

One more smart check

Taking Niacin as Part of a Dietary Supplement Product? Check It for Interactions

We hold 933 real supplement products containing Niacin, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Niacin. Even though Niacin itself has no known interaction with Tralokinumab-ldrm, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Niacin and Tralokinumab-ldrm Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Niacin
Top 25%

#222 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Tralokinumab-ldrm
Steady interest

#1,652 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Niacin reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Niacin and Tralokinumab-ldrm records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Niacin

What is Niacin?

Niacin
  • High cholesterol
  • Vitamin B3 deficiency (pellagra)
  • Heart health support
  • General energy and metabolism

Niacin (vitamin B3) is an essential nutrient your body needs for energy and metabolism, and deficiency is uncommon in most developed countries. Prescription-strength niacin has been used to adjust cholesterol levels, but high doses can cause flushing and other side effects and should only be taken under medical supervision. Always talk with a pharmacist or doctor before using high-dose niacin supplements.

Not applicable (a vitamin, not a plant part) · Tablets, extended-release tablets, capsules; also found in multivitamins and food

An interaction check asks whether these two react with each other — it does not ask whether Niacin is a good idea for someone in your situation. Here is what our Niacin record says about it on its own.

Niacin: dosing

There is no single "best" supplement dose that fits everyone, and needs vary by age, sex, and health status. For preventing deficiency, the amounts in a normal diet or a standard multivitamin are usually enough for most people.High-dose niacin used for cholesterol is a different situation and is dosed much higher than nutritional amounts—this should only be done with a prescription and medical monitoring. They can help you choose the right form and dose and watch for side effects.

From our Niacin monograph — the full record covers uses, side effects and every documented interaction.

Read the full Niacin monograph & all interactions
Medication

About Tralokinumab-ldrm injection

What Is Tralokinumab-ldrm injection Used For?

Brand name: Adbry

Adbry (tralokinumab-ldrm) is used to treat moderate-to-severe atopic dermatitis — the type of eczema that causes intense itching, rash, and skin inflammation — in adults and in adolescents 12 years of age and older. It is used when prescription topical (applied to the skin) therapies have not controlled the disease adequately, or when those therapies are not a good option.

Adbry can be used on its own or alongside topical corticosteroids (steroid creams or ointments). Topical calcineurin inhibitors (a different type of skin treatment) may be added for sensitive areas like the face, neck, or skin folds.

Most-Reported Side Effects for Tralokinumab-ldrm

From FAERS, the FDA’s public side-effect reporting system (5,530 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Dermatitis atopic 782 reports
Pruritus 601 reports
Rash 428 reports
Injection site pain 308 reports
Eczema 284 reports
See full Tralokinumab-ldrm injection drug information
Keep checking

Other Drugs & Niacin

Browse every other medication we’ve checked against Niacin — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
727Moderate
0Minor
2,102No known interaction
Moderate

727 interactions

Showing 60 of 727 moderate interactions — see all 727 on the Niacin page.

No interaction 2,102 drugs checked — show the list
Evidence & sources

Niacin References

The 66 references that drive our Niacin monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Garg R, Malinow MR, Pettinger M, et al. Niacin treatment increases plasma homocysteine levels. Am Heart J 1999;138:1082-7.
  2. Anon. Inositol hexaniacinate. Altern Med Rev 1998;3:222-3.
  3. Knodel LC, Talbert RL. Adverse effects of hypolipidaemic drugs. Med Toxicol 1987;2:10-32. PubMed
  4. Guyton JR, Blazing MA, Hagar J, et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med 2000;160:1177-84. PubMed
  5. Gibbons LW, Gonzalez V, Gordon N, Grundy S. The prevalence of side effects with regular and sustained-release nicotinic acid. Am J Med 1995;99:378-85. PubMed
  6. Whelan AM, Price SO, Fowler SF, Hainer BL. The effect of aspirin on niacin-induced cutaneous reactions. J Fam Pract 1992;34:165-8.
  7. Jungnickel PW, Maloley PA, Vander Tuin EL, et al. Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions. J Gen Intern Med 1997;12:591-6. PubMed
  8. Capuzzi DM, Guyton JR, Morgan JM, et al. Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am J Cardiol 1998;82:74-81;disc. 85U-6U. PubMed
  9. Gray DR, Morgan T, Chretien SD, Kashyap ML. Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med 1994;121:252-8. PubMed
  10. McKenney JM, Proctor JD, Harris S, Chinchili VM. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. JAMA 1994;271:672-7. DOI
  11. Knopp RH, Alagona P, Davidson M, et al. Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism 1998;47:1097-104. PubMed
  12. Knopp RH. Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing. Am J Cardiol 1998;82:24U-28U;discussion 39U-41U. PubMed
  13. Garg A, Grundy SM. Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA 1990;264:723-6. DOI
  14. Leighton RF, Gordon NF, Small GS, et al. Dental and gingival pain as side effects of niacin therapy. Chest 1998;114:1472-4. PubMed
  15. American Society of Health-System Pharmacists. ASHP Therapeutic Position Statement on the safe use of niacin in the management of dyslipidemias. Am J Health Syst Pharm 1997;54:2815-9. DOI

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Niacin and Tralokinumab-ldrm Together: Common Questions

Is it safe to take Niacin with Tralokinumab-ldrm?
We do not list a known interaction between Niacin and Tralokinumab-ldrm. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Niacin and Tralokinumab-ldrm have any of the same side effects?
Yes — our sources link each of them separately to one of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Niacin and Tralokinumab-ldrm combination checked?
Interactions in our licensed database are recorded against drug classes. Tralokinumab-ldrm is filed under 1 classification, and Niacin has documented interactions with 15 drug classes — none of Tralokinumab-ldrm's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Niacin interact with any other medications?
Yes. Niacin has 727 documented drug interactions in our database — Tralokinumab-ldrm is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Tralokinumab-ldrm interact with any supplements?
Yes. Tralokinumab-ldrm has documented interactions with 53 supplements in our database — Niacin is not one of them. The Tralokinumab-ldrm interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Tralokinumab-ldrm and Niacin?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.